Clinical

Dataset Information

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors


ABSTRACT: To evaluate the efficacy and safety of nimotuzumab in the treatment of EGFR-amplified advanced pan solid tumors (Lung/Esophageal/Gastric/Pancreatic /Colorectal / Head and neck Cervical).

DISEASE(S): Solid Tumor,Egfr Amplification,Neoplasms

PROVIDER: 90799 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR